GSK shareholders to vote on Novartis deal on December 18

LONDON (Reuters) - Britain's GlaxoSmithKline has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland's Novartis, which will see the two pharmaceutical group trade more than $20 billion (12.78 billion pounds) of assets.